Cereno Scientific has announced the company’s inclusion into the Nasdaq First North 25 Index, which consists of the 25 largest and most traded shares listed on the Nasdaq Nordic First North Growth Markets (First North Denmark, First North Finland, First North Iceland and First North Sweden). This has been driven by the strong trading performance by the company in recent months (share price has nearly doubled since April 2025 to SEK10.15), indicating shareholder optimism in its rare disease-focused developmental pipeline. We value Cereno at SEK16.0 per share.
Industrials | Comment
TMT | Comment
Industrials | Comment
Industrials | Comment